RAUL GODINA: Open Payments
NPI 1336499730 · CALDWELL, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 47 payments from 15 companies in 2025. Trend: 2023 $1,206 · 2024 $962 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $262 |
| Novo Nordisk Inc | 10 | $147 |
| Amgen Inc. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Lilly USA, LLC | 1 | $28 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
Products named: ELIQUIS, EVENITY, NURTEC ODT, LEQVIO, Wegovy, PREVNAR 20, TRELEGY ELLIPTA, Rybelsus.
Industry payments across ID — which companies pay providers there.
